Results 191 to 200 of about 160,953 (345)

Terasaki's seminal contributions in HLA and Organ Transplantation [PDF]

, 1999
Starzl, TE
core  

Severe Hypertriglyceridemia in a Patient Treated With Sirolimus for Graft-vs-Host Disease Prophylaxis. [PDF]

JCEM Case Rep
Criner K, Student J, Arkin J, Carp J, Sokoloff S.   +4 more
europepmc   +1 more source

Late follow-up of genital and ophthalmologic chronic graft-vs-host disease in females after allogeneic stem cell transplantation. [PDF]

Acta Obstet Gynecol Scand, 2022
Smith Knutsson E, Nicklasson M, Björk Y, Stenberg K, Sundfeldt K, Brune M.   +5 more
europepmc   +1 more source

Generation of Allogeneic CAR‐T Circumvents Functional Deficits in Patient‐Derived Autologous Product for Glioblastoma

International Journal of Cancer, EarlyView.
Clinical trials of chimeric antigen receptor T‐cell (CAR‐T) therapies in glioblastoma have shown limited clinical benefits. Whether this may be explained by the basal quality of CAR‐T products, which are currently generated using patient, autologous T‐cells, has been little explored.
Sabra K. Salim, Muhammad Vaseem Shaikh, Jeffrey Wei, William T. Maich, Alisha Anand, Oliver Y. Tang, Minomi K. Subapanditha, Zahra Alizada, Yujin Suk, Manoj Singh, Kui Zhai, Aapti Khanna, Benjamin Brakel, Vassil Dimitrov, Zoya Tabunshchyk, Katie Chan, Kevin R. Brown, Parvez Vora, Donald M. O'Rourke, Zev A. Binder, Chitra Venugopal, Jason Moffat, Sheila K. Singh   +22 more
wiley   +1 more source

Case Report: Diagnosis and successful treatment of a rare case of steroid-refractory chronic graft-vs-host disease-related serositis. [PDF]

Front Immunol
Xiong Z, Wang Z, Chen X.
europepmc   +1 more source

IFN-γ and PPARδ influence the efficacy and retention of multipotent adult progenitor cells in graft vs host disease. [PDF]

Stem Cells Transl Med, 2021
Carty F, Dunbar H, Hawthorne IJ, Ting AE, Stubblefield SR, Van't Hof W, English K.   +6 more
europepmc   +1 more source

Transfusion-Associated Graft-vs-Host Disease [PDF]

American Journal of Clinical Pathology, 2000
Timothy E. Gorman, Carmen J. Julius, Rolf F. Barth, A. Ng, Melanie S. Kennedy, Thomas W. Prior, James Allen, Larry C. Lasky   +7 more
openaire   +1 more source

Histopathology of Graft-vs-Host Disease of Gastrointestinal Tract and Liver:  An Update.

American Journal of Clinical Pathology, 2016
M. Salomao, K. Dorritie, M. Mapara, A. Sepulveda   +3 more
semanticscholar   +1 more source

Adverse Health Events in Chronic Myeloid Leukaemia Patients Treated With Tyrosine Kinase Inhibitors 2009–2019: A Real‐World Study From the UK's Haematological Malignancy Research Network

International Journal of Cancer, EarlyView.
Although tyrosine kinase inhibitors (TKIs) improve chronic myeloid leukemia (CML) outcome, long‐term effects remain unclear, particularly in real‐world settings. Here, the authors examined morbidity and mortality in CML patients treated with TKIs between 2009 and 2019 in the United Kingdom.
Eleanor Kane, Alexandra Smith, Debra Howell, Catherine Cargo, Kate Rothwell, Simone Green, Russell Patmore, Eve Roman   +7 more
wiley   +1 more source